{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:09:19Z","timestamp":1757700559159},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1-4","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Lab Res"],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1007\/bf02591396","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T11:43:10Z","timestamp":1175168590000},"page":"58-61","source":"Crossref","is-referenced-by-count":7,"title":["Bleeding time and antiplatelet agents in normal volunteers"],"prefix":"10.1007","volume":"22","author":[{"given":"E. M.","family":"Pogliani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fowst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bregani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Corneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02591396_CR1","doi-asserted-by":"crossref","unstructured":"Antiplatelet Trialists' Collaboration, Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ p 296, 1988","DOI":"10.1136\/bmj.296.6618.320"},{"key":"BF02591396_CR2","first-page":"469","volume":"72","author":"BJR Bailey","year":"1977","unstructured":"Bailey BJR, Tables of the Bonferroni \u201ct\u201d statistics, J Am Stat Assoc 72:469, 1977","journal-title":"J Am Stat Assoc"},{"key":"BF02591396_CR3","first-page":"17","volume-title":"Experimental design","author":"WG Cochran","year":"1950","unstructured":"Cochran WG, Cox GM, Experimental design. Wiley, New York, p 17, 1950"},{"issue":"Suppl 1","key":"BF02591396_CR4","first-page":"1769","volume":"74","author":"Volta S Dalla","year":"1989","unstructured":"Dalla Volta S, Antiplatelet treatment in the prevention of reocclusion after PTCA: an Italian multicenter study. Blood 74 [Suppl 1]:1769, 1989","journal-title":"Blood"},{"key":"BF02591396_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2007-1002699","volume":"15","author":"G Defreyn","year":"1989","unstructured":"Defreyn G, Bernat A, Delebrassee Maffraud P, Pharmacology of ticlopidine: a review. Semin Thromb Hemost 15:159, 1989","journal-title":"Semin Thromb Hemost"},{"key":"BF02591396_CR6","first-page":"1973","volume":"46","author":"DJ Ellis","year":"1981","unstructured":"Ellis DJ, Roerl Burno JJ, Cranston BJ, McSpadden MM, The effects of ticlopidine hydrochloride on bleeding time and platelet function in man. Thromb Haemost 46:1973, 1981","journal-title":"Thromb Haemost"},{"key":"BF02591396_CR7","doi-asserted-by":"crossref","unstructured":"Gent M, Easton JD, Hachinski VC, Sicurella J, Blakel JA, Ellis DJ, Harbison JW, Roberts RS, Turpie AGG, and the CATS group, The Canadian American ticlopidine study (CATS) on thromboembolic stroke. Lancet p 1217, 1989","DOI":"10.1016\/S0140-6736(89)92327-1"},{"key":"BF02591396_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","volume":"321","author":"WK Hass","year":"1989","unstructured":"Hass WK, Easton JD, Adams HP, Pryse PW, Molony BA, Anderson S, Kamm B, A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 321:501, 1989","journal-title":"N Engl J Med"},{"key":"BF02591396_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0049-3848(87)90224-6","volume":"45","author":"R Kallmann","year":"1987","unstructured":"Kallmann R, Nieuwenhuis HK, De Groot PG, Van Gijn J, Sixma JJ, Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PG F1a excretion in healthy subjects. Thromb Res 45:355, 1987","journal-title":"Thromb Res"},{"key":"BF02591396_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0049-3848(87)90399-9","volume":"48","author":"L Mannucci","year":"1987","unstructured":"Mannucci L, Maderna P, Colli S, Lavezzari M, Sirtori CR, Tremoli E, Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk. Thromb Res 48:417, 1987","journal-title":"Thromb Res"},{"key":"BF02591396_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","volume":"17","author":"C Patrono","year":"1980","unstructured":"Patrono C, Ciabattoni G, Pinca E, Pugliese F, Castrucci G, De Salvo A, Satta MA, Peskar BA, Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res 17:317, 1980","journal-title":"Thromb Res"},{"key":"BF02591396_CR12","first-page":"1","volume":"66","author":"E Pogliani","year":"1981","unstructured":"Pogliani E, Corvi G, Mandelli V, Fuccella LM, Preliminary human pharmacology studies on the inhibition of platelet aggregation by Indobufen (K 3920). Haematologica (Pavia) 66:1, 1981","journal-title":"Haematologica (Pavia)"},{"issue":"Suppl 1","key":"BF02591396_CR13","first-page":"1769","volume":"74","author":"F Rovelli","year":"1981","unstructured":"Rovelli F, Indobufen versus aspirin+dipyridamole in preventing early aortocoronary graft occlusion: a double blind randomized multicenter study. Blood 74 [Suppl 1]:1769, 1981","journal-title":"Blood"},{"issue":"Suppl A","key":"BF02591396_CR14","first-page":"238A","volume":"13","author":"F Violi","year":"1989","unstructured":"Violi F, Scrutini D, Ciminiello C et al., S.T.A.I. (Study of Ticlopidine in Unstable Angina) (abstract). J Am Coll Cardiol 13 [Suppl A]:238A, 1989","journal-title":"J Am Coll Cardiol"}],"container-title":["International Journal of Clinical & Laboratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02591396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02591396\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02591396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T19:37:43Z","timestamp":1558381063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02591396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":14,"journal-issue":{"issue":"1-4","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["BF02591396"],"URL":"https:\/\/doi.org\/10.1007\/bf02591396","relation":{},"ISSN":["0940-5437","1434-4467"],"issn-type":[{"value":"0940-5437","type":"print"},{"value":"1434-4467","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}